Lauren Stival | Head of Investor Relations |
Michael Anderson | Chief Executive Officer |
Michael Kanan | Chief Financial Officer |
Gregory Davis | Chief Operating Officer |
John Boris | SunTrust Robinson Humphrey |
Matthew Kaplan | Ladenburg Thalmann & Co. |
François Brisebois | Laidlaw Capital Markets |
Jason Butler | JMP Securities |
Good day, ladies and gentlemen, and welcome to the Avadel Pharmaceuticals Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference may be recorded. I would now like to introduce your host for today’s conference, Lauren Stival, Head of Investor Relations.